Pharma Steenokkerzeel
ActiveFrom the official registers: KBO 19 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Pharma Steenokkerzeel has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.0m and a net result of €332,125. Equity has been growing by about 14% per year since 2018. Its solvency ranks better than 95% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 31-05-2007 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730and 1 other
- Establishment unit
- 2.163.101.780 1820 Steenokkerzeel, since 01-07-2007
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2023
Board and ownership
- De Ridder Thomas BVDirector · since 07-06-2019
- Cornette An BVDirector · since 01-09-2020
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €543,652
- ▲ 46.2%
- Turnover
- ≈ €2.0m
- estimated
- Profit
- €332,125
- ▲ 64.6%
- Equity
- €1.0m
- ▲ 49.2%
- Total assets
- €1.1m
- ▲ 8.7%
- Staff
- 0.2 FTE
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 6.05, cash €397,064Equity €1.0m (90.2% of total assets)Founded in 2007Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 94% on liquidity, 96% on profitability and 86% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 14 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: Higher solvency than 95% of companies in retail tradesector median 36.6% · 12,757 companies 90.2% View
- Positive: Result rose in 2025from €201,826 to €332,125 ▲ 64.6% View
- Positive: 8 profitable years in a rowprofit 2025: €332,125 8 years View
- Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View
Comparable companies
These companies have the same main activity as Pharma Steenokkerzeel: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1m and €1.4m, founded between 2005 and 2009.
| Company | Total assets | Gross margin |
|---|---|---|
| Pharma Steenokkerzeel Steenokkerzeel | €1.1m | €0.5m |
| PHARMA BEART Manage | €1.2m | €0.5m |
| Apotheek Hilde Maeijens Eeklo | €1.1m | €0.5m |
| PHARMACIE DU RECIF Elsene | €1.2m | €0.5m |
| APOTHEEK VAN HOECKE Temse | €1.0m | €0.6m |
| APOTHEEK TANGHE Halle | €1.4m | €0.5m |
| FARMAFRANCE Halle | €1.4m | €0.6m |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 25-06-2026
- Annual accounts 2024filed on 09-07-2025
- Annual accounts 2023filed on 19-07-2024
- Annual accounts 2022filed on 29-06-2023
Acts in the Belgian Official Gazette
- Amendment of the articles · Legal-form change · Miscellaneousact of 26-10-2022
- Registered officeact of 29-08-2022
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about Pharma Steenokkerzeel
- What is the company number of Pharma Steenokkerzeel?
- The company number of Pharma Steenokkerzeel is 0889.759.719. The VAT number is the same number with BE in front: BE 0889.759.719.
- Where is Pharma Steenokkerzeel based?
- The registered office is at Haachtsesteenweg 21, 1820 Steenokkerzeel.Company details
- What does Pharma Steenokkerzeel do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Pharma Steenokkerzeel?
- The legal form of Pharma Steenokkerzeel is Private limited company (BV).
- When was Pharma Steenokkerzeel founded?
- Pharma Steenokkerzeel was founded on 31-05-2007.
- Is Pharma Steenokkerzeel still active?
- Yes, Pharma Steenokkerzeel is an active enterprise in the KBO register.
- How many employees does Pharma Steenokkerzeel have?
- Pharma Steenokkerzeel had an average of 0.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of Pharma Steenokkerzeel?
- The turnover in financial year 2025 is ≈ €2.0m. This figure is estimated from the gross margin of €543,652 and 47 comparable companies (NACE 477). It probably lies between €1.5m and €3.3m.
- Is Pharma Steenokkerzeel profitable?
- In financial year 2025, Pharma Steenokkerzeel made a profit of €332,125.
- Where can I find the annual accounts of Pharma Steenokkerzeel?
- Pharma Steenokkerzeel filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of Pharma Steenokkerzeel due?
- Pharma Steenokkerzeel must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.